Ovarian cancer complications: clinical challenges following surgical rupture
NCODA Oncology and Hematology Meeting Abstracts · 15.06.2026
DOI: 10.67209/cvhr4093 ↗Kurz gefasst
Fachartikel in der Zeitschrift NCODA Oncology and Hematology Meeting Abstracts, online erschienen am 15.06.2026. Verfasst von Kyla Ellis und 1 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Intraoperative rupture of ovarian tumors is a known risk factor for recurrence and disease upstaging. According to the International Federation of Gynecology and Obstetrics (FIGO) guidelines, tumor rupture during surgery advances staging to at least IC1, carrying a poorer prognosis compared to tumors confined within the ovary without surface involvement or rupture. This case describes a 41-year-old woman with FIGO stage IC1, grade 2 endometrioid ovarian adenocarcinoma complicated by surgical rupture and peritoneal fluid, which contributed to recurrence despite initial treatment success. This case aims to illustrate the clinical course and management of recurrent endometrioid ovarian carcinoma following surgical rupture, with a focus on complications during chemotherapy and transitions to surveillance.
Zitieren
APA
Ellis, K., & Steward, C. (2026). Ovarian cancer complications: clinical challenges following surgical rupture. NCODA Oncology and Hematology Meeting Abstracts. https://doi.org/10.67209/cvhr4093
Vancouver
Ellis K, Steward C. Ovarian cancer complications: clinical challenges following surgical rupture. NCODA Oncology and Hematology Meeting Abstracts. 2026. doi:10.67209/cvhr4093
BibTeX
@article{Ellis2026,
author = {Ellis, Kyla and Steward, Cortney},
title = {Ovarian cancer complications: clinical challenges following surgical rupture},
journal = {NCODA Oncology and Hematology Meeting Abstracts},
year = {2026},
doi = {10.67209/cvhr4093}
}
EUVIMED